LONDON (AP) — LONDON (AP) — GSK plc (GSK) on Wednesday reported third-quarter net income of $2.07 billion.
On a per-share basis, the London-based company said it had net income of $1.02. Earnings, adjusted for restructuring costs and amortization costs, came to $1.47 per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.40 per share.
The drug developer posted revenue of $11.95 billion in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $11.8 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GSK at https://www.zacks.com/ap/GSK
